Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study
Authors:
Abstract
No abstract availableKeywords
Funding Information
- SANOFI PASTEUR S.A., France, Becton, Dickinson and Company, USA
- Nissui Pharmaceutical Co., Ltd., Japan
- bioMérieux SA, France
This publication has 28 references indexed in Scilit:
- Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID)The Lancet Infectious Diseases, 2014
- A Multicenter Study ofClostridium difficileInfection—Related Colectomy, 2000—2006Infection Control & Hospital Epidemiology, 2012
- Multidrug resistance in European Clostridium difficile clinical isolatesJournal of Antimicrobial Chemotherapy, 2011
- Clostridium difficile infection in Europe: a hospital-based surveyThe Lancet, 2011
- Multicenter Study of Clostridium difficile Infection Rates from 2000 to 2006Infection Control & Hospital Epidemiology, 2010
- Clostridium difficileIsolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018Journal of Clinical Microbiology, 2010
- Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typingJournal of Medical Microbiology, 2010
- Rapid and Simple Method for Detecting the Toxin B Gene of Clostridium difficile in Stool Specimens by Loop-Mediated Isothermal AmplificationJournal of Clinical Microbiology, 2005
- Analysis of Clostridium difficile Isolates from Nosocomial Outbreaks at Three Hospitals in Diverse Areas of JapanJournal of Clinical Microbiology, 2001
- Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficileFEMS Microbiology Letters, 2000